Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway
Cui-Li Zhang1, Tao Zeng1, Xiu-Lan Zhao1
1Institute of Toxicology, School of Public Health, Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong, P.R. China.
Abstract:
To explore the underlying mechanisms for the protective effects of garlic oil (GO) against nitrosodiethylamine (NDEA)-induced hepatocarcinoma, 60 male Wistar rats were randomized into 4 groups (n=15): control group, NDEA group, and two GO plus NDEA groups. The rats in GO plus NDEA groups were pretreated with GO (20 or 40 mg/kg) for 7 days. Then, all rats except those in control group were gavaged with NDEA for 20 weeks, and the rats in GO plus NDEA groups were continuously administered with GO. The results showed that GO co-treatment significantly suppressed the NDEA-induced increases of alpha fetal protein (AFP) level in serum, nuclear atypia in H&E staining, sirius red-positive areas and proliferating cell nuclear antigen (PCNA) expression. The molecular mechanisms exploration revealed that the protein levels of phosphatidylinositol 3 kinase (PI3K)-p85, PI3K-p110, total AKT, p-AKT (Ser473) and p-AKT (Thr308) in the liver of NDEA group rats were higher than those in control group rats. In addition, NDEA treatment induced IκB degradation and NF-κB p65 phosphorylation, and up-regulated the protein levels of downstream pro-inflammatory mediators. GO co-treatment significantly reversed all the above adverse effects induced by NDEA. These results suggested that the protective effects of GO against NDEA-induced hepatocarcinoma might be associated with the suppression of PI3K- AKT-NF-κB pathway.
Insights
Garlic oil (GO) protects against liver cancer induced by nitrosodiethylamine (NDEA) in rats. GO suppresses key cancer markers and the PI3K-AKT-NF-κB signaling pathway, offering a potential therapeutic strategy.
Area of Science:
- Hepatocellular Carcinoma Research
- Natural Product Chemistry
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) poses a significant global health challenge.
- Nitrosodiethylamine (NDEA) is a known carcinogen used to induce HCC in experimental models.
- Investigating natural compounds for chemopreventive properties is crucial for developing novel therapies.
Purpose of the Study:
- To elucidate the protective mechanisms of garlic oil (GO) against NDEA-induced hepatocarcinoma in a rat model.
- To assess the impact of GO on key biomarkers of liver cancer progression.
- To explore the molecular pathways modulated by GO in hepatocarcinogenesis.
Main Methods:
- Rats were divided into control, NDEA-induced, and GO + NDEA groups.
- GO was administered at 20 or 40 mg/kg before and during NDEA exposure for 20 weeks.
- Serum alpha fetal protein (AFP), histological analysis (H&E, Sirius Red), PCNA expression, and Western blotting for PI3K/AKT/NF-κB pathway proteins were performed.
Main Results:
- GO co-treatment significantly reduced NDEA-induced increases in serum AFP, nuclear atypia, and Sirius Red-positive areas.
- GO suppressed proliferating cell nuclear antigen (PCNA) expression, indicating reduced cell proliferation.
- GO reversed NDEA-induced upregulation of PI3K, AKT phosphorylation, IκB degradation, and NF-κB activation.
Conclusions:
- Garlic oil demonstrates significant protective effects against NDEA-induced hepatocarcinoma in rats.
- GO's chemopreventive action is linked to the suppression of the PI3K-AKT-NF-κB signaling pathway.
- These findings suggest GO as a potential therapeutic agent for preventing or treating liver cancer.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...